Health
FRONTIER BIOTECHNOLOGIES ANNOUNCES POSITIVE PHASE 1 RESULTS OF ITS FIRST CORONAVIRUS MAIN PROTEASE (MPRO) SMALL MOLECULE INHIBITOR, LAYING FOUNDATION FOR THE TREATMENT OF ACUTE AND LONG COVID
* FB2001 (Bofutrelvir) is a Coronavirus Mpro inhibitor, which exhibited potent anti-SARS-CoV-2 activityin vitro and in vivo * Phase 1 results show FB2001 to be generally safe and well tolerated. No significant difference was observed between Chinese and American populations. Single-agent anti...
2022-08-09 00:00
2786
Point-of-Care Ultrasound Certification Academy to Host World Conference
Ultrasound leaders from around the world will gather virtually to help define thelatest innovations in point-of-care ultrasound ROCKVILLE, Md., Aug. 8, 2022 /PRNewswire/ -- The global point-of-care ultrasound (POCUS) community, consisting of numerous specialties of healthcare providers, will ga...
2022-08-08 21:00
1855
Amwell Applauded by Frost & Sullivan for its Comprehensive Digital Care Delivery Enablement Platform, Converge™
The Converge platform enables healthcare organizations to deliver better outcomes, improve operational efficiency, and achieve digital care delivery aspirations, benefiting patients and providers alike. SAN ANTONIO, Aug. 8, 2022 /PRNewswire/ -- Recently, Frost & Sullivan researched the virtual c...
2022-08-08 20:00
2150
Prominent Stanford University scientist and cellular reprogramming innovator will oversee all research for Turn Bio
Vittorio Sebastiano, globally recognized for pioneering science, expands his role at company he co-founded as it moves closer to clinical research MOUNTAIN VIEW, Calif., Aug. 8, 2022 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreata...
2022-08-08 20:00
2211
Catalytic Investment to Improve Community Health Care for Millions Across Africa
The Global Fund collaborates with the Johnson & Johnson Foundation and the Skoll Foundation to Launch the Africa Frontline First Catalytic Fund * Private sector investments to the Global Fund's Africa Frontline First Catalytic Fund from the Johnson & Johnson Foundation and the Skoll Foundation ...
2022-08-08 19:07
1801
Prenetics Launches Circle Snapshot, Simple At-home Blood Tests Using the World's First Push-Button and Painless Blood Collection Device
- Circle Snapshot, a patented, painless, at-home blood test with laboratory results delivered digitally. - The test utilises a CE-certified blood collection device, which is a proprietary micro-needle technology that draws capillary blood painlessly using a novel microfluidic extraction process....
2022-08-08 16:45
3178
COCA-COLA, FINE HYGIENIC HOLDING, BIC, CIGNA, VIATRIS, ACCENTURE TO LEAD AT 2022 MIDDLE EAST EDITION OF BREAK THE CEILING TOUCH THE SKY®
MISSION 2029 FOR A BETTER WORLD continues to advance gender equality globally. DUBAI, UAE, Aug. 8, 2022 /PRNewswire/ -- House of Rose Professional Pte. Ltd (HORP)today announced that top executives from Coca-Cola, Fine Hygienic Holding, BIC, Cigna, Viatrisand Accenture would lead a field of C-Su...
2022-08-08 16:04
1758
BEYOND Expo 2022 Early Bird Booth Registration - Ending August 31st
MACAU, Aug. 8, 2022 /PRNewswire/ -- The BEYOND Expo Organizing Committee has officially released the details for BEYOND Expo 2022. Due to COVID-19 restrictions, it will be held virtually fromSeptember 21st-27th in the metaverse. The conference will host exclusive summits on investment and web3, ...
2022-08-08 13:05
4662
Xinhua Silk Road: E. China's Wuxi city steps up biomedical industry development
BEIJING, Aug. 8, 2022 /PRNewswire/ -- The 2022 Taihu Bay Future Healthcare Conference held Thursday in Wuxi City in eastChina's Jiangsu Province witnessed the launch of Wuxi Intellectual Property Protection Center with 52 biomedical projects contracted, involving a total of more than30 billion yu...
2022-08-08 12:24
2414
Qmed Asia launches Qmed GO "Mini Clinics" to Solve Rising Employee Healthcare Costs
Disrupting the medical landscape through an innovative internet-enabled
clinical kiosk.
KUALA LUMPUR, Malaysia, Aug. 8, 2022 /PRNewswire/ -- Qmed Asia
2022-08-08 10:15
2510
BIO Asia-Taiwan 2022 concludes, marking another successful edition of the region's biggest bioindustry-focused conference and exhibition
Exhibition visitors surpass 100,000 people over 4 days BIO Asia–Taiwan success a testament to Taiwan's booming biotechnology industry TAIPEI, Aug. 8, 2022 /PRNewswire/ -- BIO Asia–Taiwan 2022, held at the TaiNEX 2 Exhibition Center, Nangang,Taipei, from 27-31 July, came to a successful conclusio...
2022-08-08 10:00
4929
BioDuro-Sundia and X-Chem enter partnership to launch DEL services in China for the discovery of new small molecule drugs
SHANGHAI, Aug. 8, 2022 /PRNewswire/ -- BioDuro-Sundia, an industry-leading drug discovery, development and commercial service CRDMO backed by Advent International, and X-Chem, a DEL technology pioneer in small molecule drug discovery, jointly announced the launch of DNA Encoded Compound Library (...
2022-08-08 09:06
2232
Ascletis Announces First Patient Dosed in the U.S. Phase I Clinical Trial of Oral PD-L1 Small Molecule Inhibitor Prodrug ASC61 for Treatment of Advanced Solid Tumors
--ASC61 is an in-house developed oral PD-L1 small molecule inhibitor prodrug that showed significant antitumor efficacy in preclinical studies as a single agent in multiple animal models --ASC61-A treatment induced secretion of IFNγ in a concentration dependent manner with an EC50 of 2.86 nM. Ma...
2022-08-08 08:10
2163
CStone presents updated results of a registrational study of sugemalimab in patients with stage III NSCLC via oral presentation at WCLC 2022
* GEMSTONE-301 study result was presented at IASLC 2022 World Conference on Lung Cancer. In addition, the leading Principal Investigator ProfessorYi-Long Wu was invited to highlight key data in a press conference * In the final progression-free survival analysis, sugemalimab showed sustained ...
2022-08-08 08:08
2080
Innovent Announces First Patient Dosed in Phase 1 Study of IBI324 (VEGF-A/Ang-2 Bispecific Antibody) in Patients with Diabetic Macular Edema
SAN FRANCISCO and SUZHOU, China, Aug. 8, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and ...
2022-08-08 08:00
2348
Transcenta Announces the Appointment of Dr. Caroline Germa as Executive Vice President, Global Medicine Development and Chief Medical Officer
SUZHOU, China, Aug. 8, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics,announces the appointment of Dr. ...
2022-08-08 08:00
2188
Telix and University of Queensland-led Consortium Awarded $5M Australian Research Council (ARC) Grant
MELBOURNE, Australia, Aug. 8, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has been jointly awarded a$4.8 million Australian Research Council (ARC) grant to establish a new Industrial Transformation Research Program (ITRP) Hub as part o...
2022-08-08 07:55
2217
BGI's Global Life Science Research Leadership Recognized in 2022 Nature Index
SHENZHEN, China, Aug. 5, 2022 /PRNewswire/ -- BGI's leading global position in life science research has been recognized in the 2022 Nature Index. BGI rose two places to 8th in the world among corporate institutions for its contribution to life science research and was the only Chinese corporate ...
2022-08-05 22:18
5222
Vieworks Wins FDA Approval for Its Newest VIVIX-S F series
ANYANG, South Korea, Aug. 5, 2022 /PRNewswire/ -- Vieworks, a leading digital X-ray imaging solution provider based inSouth Korea, noted that its newest VIVIX-S F series has been authorized by the US Food and Drug Administration (FDA) last July. Regulatory clearance from the FDA will allow Viewor...
2022-08-05 21:00
7473
Hisense South Africa Donates an Ultrasound HD60 to The Peninsular Maternity Trust for Mowbray Maternity Hospital
CAPE TOWN, South Africa, Aug. 5, 2022 /PRNewswire/ -- At a donation ceremony on July 28, Hisense, a manufacturer and provider of high-performance electronics and medical devices, delivered a cutting-edge, high-resolution, ultrasound machine, the Hisense Ultrasound HD60, to the Peninsula Maternity...
2022-08-05 15:13
1325
Week's Top Stories
Most Reposted
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 313 media titles]
2024-05-15 12:00
Thousands set to gather in Singapore for Rotary's international convention, the Garden City's largest association event post-pandemic
[Picked up by 289 media titles]
2024-05-09 11:00
i2Cool Attracts Close to HKD100 Million in Series A Financing to Propel the Development of Green and Energy-Efficient Radiant Cooling Solutions
[Picked up by 283 media titles]
2024-05-09 10:50
Central Embassy, celebrates its 10th anniversary with a world-class immersive presentation--the first of its kind in Thailand--by renowned artist Daniel Arsham
[Picked up by 272 media titles]
2024-05-10 15:20
Where does China's production capacity come from?
[Picked up by 258 media titles]
2024-05-10 12:01Most Read
Thousands set to gather in Singapore for Rotary's international convention, the Garden City's largest association event post-pandemic
2024-05-09 11:00
12145
Cision's 2024 State of the Media Report: Journalists Battle Misinformation, Embrace Data, and Seek PR Partnership
2024-05-09 10:00
7679
i2Cool Attracts Close to HKD100 Million in Series A Financing to Propel the Development of Green and Energy-Efficient Radiant Cooling Solutions
2024-05-09 10:50
7422
Huawei Launching the All-Scenario Smart Telecom Power Solutions
2024-05-11 17:52
6754
